High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.8M
$10,778,252
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
Equity Compensation
2026-01-06
$1,805,170Largex2
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
Equity Compensation
|
2026-01-06 | $1,805,170Largex2 | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
10b5-1 SellΔOwn -20.2%
2026-01-06
$4,394,252Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
10b5-1 SellΔOwn -20.2%
|
2026-01-06 | $4,394,252Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
10b5-1 SellΔOwn -13.5%
2025-12-03
$6,384,000Whalex2
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
10b5-1 SellΔOwn -13.5%
|
2025-12-03 | $6,384,000Whalex2 | S | Form 4 |